期刊文献+

中性粒细胞与淋巴细胞比值变化对肺大细胞神经内分泌癌患者预后的影响 被引量:6

The predictive value of pre-and postoperative neutrophil-lymphocyte ratio for pulmonary large cell neuroendocrine carcinoma patients
原文传递
导出
摘要 目的 探讨肺大细胞神经内分泌癌患者手术治疗前后外周血中性粒细胞/淋巴细胞比值(NLR)对预后的影响.方法 分析28例肺大细胞神经内分泌癌患者临床资料,单因素分析年龄、吸烟指数、病理类型、肿瘤分期、术前术后NLR、和术前NLR/术后NLR比值等对预后的影响,差异有统计学意义的单因素进入Cox回归模型进行多因素分析.结果 单因素分析显示年龄(P<0.05)、吸烟指数(P<0.05)、病理类型(P<0.05)、肿瘤分期(P<0.05)、术前NLR≥2.5(P <0.05)和术后NLR≥3.5(P<0.05)影响患者预后.Cox回归分析显示肿瘤分期(P<0.05)、术前NLR≥2.5(P <0.05)和术后NLR≥3.5(P <0.05)为影响患者术后生存率的独立危险因素.结论 对于接受手术的肺大细胞神经内分泌癌患者,术前术后NLR升高可能提示其预后不良. Objective To analyze the impact of pre-and postoperative neutrophil-lymphocyte ratio (NLR) on the survival of patients with pulmonary large cell neuroendocrine carcinoma (LCNEC).Methods The clinical data of 28 patients with pulmonary LCNEC were retrospectively reviewed,and the predictors of univariate analyses included gender,age,smoking history,pathological type and tumor stage,pre-and postoperative neutrophil-lymphocyte ratio (NLR) and preoperative NLR/postoperative NLR,etc.The analysis of Cox multiple regression was performed to determine the parameters of predicting the LCNEC prognosis.Results Univariate analysis showed that age (P 〈 0.05),smoking history (P 〈 0.05),pathological type (P 〈 0.05),tumor stage (P 〈 0.05),preoperative NLR ≥2.5 (P 〈 0.05) and postoperative NLR ≥ 3.5 (P 〈 0.05) were prognostic factors.Multivariate analysis revealed that tumor stage (P 〈0.05),preoperative NLR ≥2.5 (P 〈0.05) and postoperative NLR ≥3.5 (P 〈 0.05) were independent prognostic factors.Conclusion The elevated pre-and postoperative NLR may predict the LCNEC patients with a poor prognosis after surgery.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第12期2900-2902,共3页 Chinese Journal of Experimental Surgery
关键词 肺癌 神经内分泌癌 手术 预后 Pulmonary carcinoma Neuroendocrine carcinoma Surgery Prognosis
  • 相关文献

参考文献10

  • 1Travis WD,Linnoila RI,Tsokos MG,et al.Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma.An ultrastructural,immunohistochemical,and flow cytometric study of 35 cases[J].Am J Surg Pathol,1991,15(6):529-553.
  • 2Battafarano R,Fernandez F,Ritter J,et al.Large cell neuroendocrine carcinoma:an aggressive furm of nonsmall lung cancer[J].J Thorae Cardiovasc Surg,2005,130(1):166-172.
  • 3Rossi G,Cavazza A,Marchioni A,et al.Role of chemotherapy and the receptor tyrosine kinases KIT,PDGFR-alpha,PDGFR-beta,and met in large-cell neuroendocrine carcinoma of the lung[J].J Clin Oncol,2005,23(34):8774-8785.
  • 4Sarraf KM,Belcher E,Raevsky E,et al.Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer[J].J Thorac Cardiovasc Surg,2009,137(2):425-428.
  • 5Tomita M,Shimizu T,Ayabe T,et al.Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for nonsmall cell lung cancer[J].Anticancer Res,2011,31(9):2995-2998.
  • 6Teramukai S,Kitano T,Kishida Y,et al.Pretreatment neutrophil count as an independent prognostic factor in advanced non-small cell lung cancer:an analysis of Japan Multinational Trial Organisation LC00-03[J].Eur J Cancer,2009,45(11):1950-1958.
  • 7余发斌,熊斌,宋海滨,李春光,毛明,兰海.胃癌外周血中性粒细胞与淋巴细胞比值及临床病理指标的关系[J].中华实验外科杂志,2013,30(8):1734-1736. 被引量:10
  • 8张秀峰,张筱骅,周素梅,万丽,陈国荣,郝儒田,胡孝渠.中性粒细胞相关载脂蛋白在乳腺癌的表达及意义[J].中华实验外科杂志,2008,25(8):1018-1020. 被引量:3
  • 9李力群,高建华,鲁峰,察鹏飞,鲁华.金属硫蛋白对皮瓣存活及细胞凋亡基因的影响[J].中华实验外科杂志,2011,28(1):57-59. 被引量:3
  • 10Motomura T,Shirabe K,Mano Y,et al.Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment[J].J Hepatol,2013,58(1):58-64.

二级参考文献32

  • 1张涤生.整复外科的实验研究和创新发展观[J].中华实验外科杂志,2006,23(6):645-647. 被引量:5
  • 2郑岩,易成刚,郭树忠,王文勇,胡学昱,刘丹.转基因的骨髓间充质干细胞治疗大鼠缺血皮瓣[J].中华实验外科杂志,2007,24(3):339-342. 被引量:13
  • 3Zhang H, Xu L, Xiao D, et al. Upregulation of neutrophil gelatinase- associated lipocalin in oesophageal squamous cell carcinoma:significant correlation with cell differentiation and tumour invasion. J Clin Pathol, 2007,60 : 555 -561.
  • 4Lim R,Ahmed N, Borregaard N, et al. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer:NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer,2007,120:2426-2434.
  • 5Woo JS, Kim KM, Kang JS, et al. Expression of neutrophil gelatinase- assoeiated lipocalin in human salivary glands. Ann Otol Rhinol Laryngol,2007,116:599-603.
  • 6Bauer M, Eickhoff JC, Gould MN, et al. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat ,2008,108:389-397.
  • 7Yang J, Goetz D, Li JY, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell ,2002,10 : 1045-1056.
  • 8Yan L,Borregaard N,Kjeldsen L,et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem, 2001,276:37258-37265,
  • 9Stoesz SP, Gould MN. OVerexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas. Oncogene, 1995,11:2233-2241.
  • 10Sato N,Fukushima N, Matsubayashi H, et al. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene, 2004; 23: 1531- 1538.

共引文献13

同被引文献63

  • 1Paul M Hofman.Pathobiology of the neutrophil-intestinal epithelial cell interaction:Role in carcinogenesis[J].World Journal of Gastroenterology,2010,16(46):5790-5800. 被引量:9
  • 2Travis WD.Advances in neuroendocrine lung tumors[J].Ann Oncol,2010,21 (7):65-71.
  • 3Tsuta K,Kalhor N,Raso MG,et al.Oncocytic neuroendocrine tumors of the lung:histopathologic spectrum and immunohistochemical analysis of 15 cases[J].Hum Pathol,2011,42 (4):578-585.
  • 4Schnabel PA,Junker K.Neuroendocrine tumors of the lungs:From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia[J].Pathologe,2014,35 (6):557-564.
  • 5Vodicka J,Spidlen V,Klecka J,et al.Surgical treatment of pulmonary carcinoids ten-year results[J].Zentralbl Chir,2011,136 (6):598-603.
  • 6Carter BW,Glisson BS,Truong MT,et al.Small cell lung carcinoma:staging,imaging,and treatment considerations[J].Radiographics,2014,34(6):1707-1721.
  • 7Rekhtman N.Neuroendocrine tumors of the lung:an update[J].Arch Pathol Lab Med,2010,134(11) 1628-1638.
  • 8Zheng G,Ettinger DS,Maleki Z.Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors[J].Acta Cytol,2013,57 (3):281-290.
  • 9Fan Z,Schraeder R.The changing pathology of lung cancer[J].Surg Oneol Clin N Am,2011,20(4):637-653.
  • 10Zahel T,Krysa S,Herpel E,et al.Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach[J].Virchows Arch,2012,460(3):299-308.

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部